Adam Linder
Impact in
- Family Practice top 2%
Papers in
-
- Nosocomial Infections in ICU 9
- Trauma, Hemostasis, Coagulopathy, Resuscitation 8
- Co-authors
- Per ÅkessonJane FisherJohn H. BoydBértil ChristenssonKeith R. WalleyLars BjörckHeiko HerwaldBjörn Dahlbäck
- Journals
- Critical Care (8 papers)Critical Care Medicine (7 papers)Open Forum Infectious Diseases (6 papers)Intensive Care Medicine Experimental (4 papers)Journal of Innate Immunity (4 papers)
- Partner nations
- SwedenCanadaUnited States
In The Last Decade
Adam Linder
95 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 120
- Critical Care and Intensive Care Medicine 360
- Family Practice 94
- Nephrology 283
- Epidemiology 1.4k
- Microbiology 185
Countries citing papers authored by Adam Linder
This map shows the geographic impact of Adam Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Linder more than expected).
Fields of papers citing papers by Adam Linder
This network shows the impact of papers produced by Adam Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Linder. The network helps show where Adam Linder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam Linder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 26 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 26 | |
| 14 | 2019 | 21 | |
| 15 | 2019 | 83 | |
| 16 | 2019 | 20 | |
| 17 | 2017 | 11 | |
| 18 | 2014 | 27 | |
| 19 | 2012 | 83 | |
| 20 | 2009 | 42 |
About Adam Linder
Adam Linder is a scholar working on Critical Care and Intensive Care Medicine, Family Practice, Epidemiology, Microbiology and Emergency Medicine, having authored 100 papers that have together received 2.8k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (45 papers), Streptococcal Infections and Treatments (17 papers), Immune Response and Inflammation (12 papers), Bacterial Infections and Vaccines (9 papers), Nosocomial Infections in ICU (9 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (8 papers), Pneumonia and Respiratory Infections (7 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (360 citations), Family Practice (94 citations), Nephrology (283 citations), Epidemiology (1.4k citations) and Microbiology (185 citations). Adam Linder has collaborated with scholars based in Sweden, Canada and United States. Frequent co-authors include Per Åkesson, Jane Fisher, John H. Boyd, Bértil Christensson, Keith R. Walley, Lars Björck, Heiko Herwald, Björn Dahlbäck, Johan Malmström and Christofer Karlsson. Their work appears in journals such as Critical Care, Critical Care Medicine, Open Forum Infectious Diseases, Intensive Care Medicine Experimental and Journal of Innate Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.